How Long Does It Take for Retatrutide to Work?

For laboratory and research use only. Not for human consumption.

The Short Answer

Most people notice appetite changes within the first one to two weeks on retatrutide. Measurable weight loss typically begins by week four. Significant results — the kind you can see in the mirror — show up around weeks 12 to 24.

But here is the key detail: retatrutide does not stop working at 24 weeks. Clinical trial data shows participants were still losing weight at 48 weeks, with no plateau in sight.

Let us break it down week by week.

Week-by-Week Timeline Based on Clinical Trials

The most important retatrutide data comes from a phase 2 clinical trial published in the New England Journal of Medicine in 2023. This study enrolled 338 adults with obesity and tested multiple dose levels over 48 weeks (PMC10844714).

Weeks 1-2: Appetite Suppression Begins

Retatrutide starts at a low dose and gradually increases — a process called titration. Even at starting doses, many participants reported noticeable appetite reduction within the first two weeks.

What this feels like: less interest in food between meals, smaller portions feeling satisfying, reduced snacking urges. The “food noise” — that constant mental chatter about what to eat next — begins to quiet down.

Weeks 4-8: Measurable Weight Loss

By week four, the scale starts to move for most people. By week eight, the changes are consistent and measurable.

At the highest dose (12 mg), participants in the clinical trial had already lost an average of about 5-8% of their body weight by this stage. For someone weighing 100 kg (220 lbs), that is 5-8 kg (11-18 lbs).

This is also when side effects are most noticeable, because the dose is still being increased. Nausea, constipation, and diarrhea are the most commonly reported issues, but they tend to improve as the body adjusts to each new dose level.

Weeks 12-24: Significant Results

This is where retatrutide really separates itself from other peptides.

At 24 weeks, the average weight loss at the 12 mg dose was 17.5%. For that same 100 kg person, that is 17.5 kg (38.5 lbs) — a dramatic change.

The numbers across dose groups at 24 weeks:

Dose	Average Weight Loss at 24 Weeks
1 mg	-7.2%
4 mg	~12-14%
8 mg	~15-17%
12 mg	-17.5%
Placebo	-1.6%

Weeks 24-48: Still Going

Here is what makes retatrutide remarkable: the weight loss did not plateau at 24 weeks. Participants kept losing weight through week 48.

Final results at 48 weeks:

Dose	Average Weight Loss at 48 Weeks
1 mg	-8.7%
4 mg	-17.1%
8 mg	-22.8%
12 mg	-24.2%
Placebo	-2.1%

At the 12 mg dose: 100% of participants lost at least 5% of their body weight. 93% lost at least 10%. And 83% lost at least 15%. These are among the highest weight loss percentages ever recorded in a clinical trial for any medication.

And the weight-loss curves had not flattened out yet — meaning participants might have continued losing weight beyond 48 weeks if the trial had continued.

How Does Retatrutide Compare to Semaglutide and Tirzepatide?

Retatrutide is a triple-receptor agonist — it hits three targets (GLP-1, GIP, and glucagon receptors) compared to semaglutide’s one (GLP-1 only) and tirzepatide’s two (GLP-1 and GIP).

A meta-analysis comparing all three found (PMC12026077):

Peptide	Targets	Max Weight Loss (vs Placebo)
Semaglutide	GLP-1	~14%
Tirzepatide	GLP-1 + GIP	~18-20%
Retatrutide	GLP-1 + GIP + Glucagon	~22-24%

Retatrutide produced the highest weight loss of the three, but it also had more adverse events. The glucagon receptor activation is thought to contribute extra fat burning but also causes more gastrointestinal side effects (PMC12190491).

In terms of onset speed, all three show appetite changes within the first 1-2 weeks. The main difference is in peak results, not how fast they start working.

Factors That Affect Your Timeline

Not everyone responds at the same speed. Here is what influences how quickly retatrutide works:

• Starting dose and titration speed — higher starting doses produce faster results but more side effects. Most protocols start low and increase gradually
• Diet quality — people who prioritize protein and whole foods during treatment tend to see better outcomes. Read our peptides and diet guide for more
• Exercise — adding resistance training protects muscle mass and may accelerate fat loss
• Starting weight — people with higher starting body weight often lose a larger absolute amount but a similar percentage
• Individual biology — some people are naturally more responsive to GLP-1 receptor activation than others

The Bottom Line

Retatrutide is the most potent weight-loss peptide studied to date. Appetite changes start within 1-2 weeks. The scale moves by week 4. And at 48 weeks, the average person on the highest dose had lost nearly a quarter of their body weight — with no plateau in sight.

If you are considering retatrutide, patience matters. The first few weeks are about titration and adjustment. The real transformation unfolds over months, not days.

Summary of Key Research References

Reference	Authors / Year	Focus	PMC ID
Triple-hormone-receptor agonist retatrutide for obesity — a phase 2 trial	Jastreboff et al., 2023	Primary retatrutide efficacy data	PMC10844714
Retatrutide — a game changer in obesity pharmacotherapy	Various, 2025	Retatrutide mechanism and context	PMC12190491
Efficacy and safety of retatrutide: a systematic review and meta-analysis	Various, 2025	Retatrutide meta-analysis	PMC12026077
Effects of once-weekly subcutaneous retatrutide: a systematic review	Various, 2024	Metabolic markers and weight loss	PMC11420505

Written by NorthPeptide Research Team

For laboratory and research use only. Not for human consumption.